Related Experiment Video
Updated: Aug 5, 2025

Kinase Inhibitor Screening In Self-assembled Human Protein Microarrays
Published on: October 23, 2019
Combining machine learning and structure-based approaches to develop oncogene PIM kinase inhibitors
Haifa Almukadi1, Gada Ali Jadkarim2, Arif Mohammed3
1Department of Pharmacology and Toxicology, Faculty of Pharmacy, King Abdulaziz University, Jeddah, Saudi Arabia.
Abstract:
Introduction: PIM kinases are targets for therapeutic intervention since they are associated with a number of malignancies by boosting cell survival and proliferation. Over the past years, the rate of new PIM inhibitors discovery has increased significantly, however, new generation of potent molecules with the right pharmacologic profiles were in demand that can probably lead to the development of Pim kinase inhibitors that are effective against human cancer. Method: In the current study, a machine learning and structure based approaches were used to generate novel and effective chemical therapeutics for PIM-1 kinase. Four different machine learning methods, namely, support vector machine, random forest, k-nearest neighbour and XGBoost have been used for the development of models. Total, 54 Descriptors have been selected using the Boruta method. Results: SVM, Random Forest and XGBoost shows better performance as compared to k-NN. An ensemble approach was implemented and, finally, four potential molecules (CHEMBL303779, CHEMBL690270, MHC07198, and CHEMBL748285) were found to be effective for the modulation of PIM-1 activity. Molecular docking and molecular dynamic simulation corroborated the potentiality of the selected molecules. The molecular dynamics (MD) simulation study indicated the stability between protein and ligands. Discussion: Our findings suggest that the selected models are robust and can be potentially useful for facilitating the discovery against PIM kinase.
Insights
Researchers developed novel PIM-1 kinase inhibitors using machine learning and structure-based methods. Four potent molecules were identified, showing promise for developing effective cancer therapeutics.
Area of Science:
- Medicinal Chemistry
- Computational Biology
- Drug Discovery
Background:
- PIM kinases are implicated in various cancers by promoting cell survival and proliferation.
- There is a demand for potent PIM kinase inhibitors with favorable pharmacologic profiles for cancer therapy.
Purpose of the Study:
- To generate novel and effective chemical therapeutics for PIM-1 kinase using integrated approaches.
- To identify potent PIM-1 inhibitors with potential for cancer treatment.
Main Methods:
- Employed machine learning (SVM, Random Forest, k-NN, XGBoost) and structure-based techniques.
- Utilized Boruta method for descriptor selection and an ensemble approach for model development.
- Validated potential inhibitors using molecular docking and molecular dynamics simulations.
Main Results:
- Support Vector Machine (SVM), Random Forest, and XGBoost models demonstrated superior performance over k-NN.
- Identified four potential PIM-1 modulating molecules: CHEMBL303779, CHEMBL690270, MHC07198, and CHEMBL748285.
- Molecular dynamics simulations confirmed the stability of protein-ligand interactions for the identified molecules.
Conclusions:
- The developed machine learning models are robust and effective for PIM kinase inhibitor discovery.
- The identified molecules hold potential for the development of novel PIM kinase inhibitors against human cancers.
More Related Videos
10:33Development of Inhibitors of Protein-protein Interactions through REPLACE: Application to the Design and Development Non-ATP Competitive CDK Inhibitors
Published on: October 26, 2015
22:10Multi-target Parallel Processing Approach for Gene-to-structure Determination of the Influenza Polymerase PB2 Subunit
Published on: June 28, 2013
Related Concept Videos
Protein-protein Interfaces
Structure-Activity Relationships and Drug Design
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence...